COLL Net Income Growth
Collegium Pharmaceutical Inc · Net Income Growth
COLL Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported32.10%period ending
COLL TTM Net Income YoY % (-52.14% → 32.10%)
Year-over-year change
High-resolution chart · PNG
COLL net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 32.1028% | |
| 70.75% | |
| -9.1343% | |
| -34.0328% | |
| -63.6901% | |
| -52.9509% | |
| 43.6819% | |
| 882.6309% | |
| 995.0184% | |
| 417.7697% | |
| 292.6046% | |
| 121.0472% | |
| 68.3358% | |
| -168.6182% | |
| -134.9595% | |
| -141.3848% | |
| -133.0195% | |
| 1.9588% | |
| 167.3333% | |
| 488.3533% | |
| 53,813.6364% | |
| 433.7894% | |
| 217.7361% | |
| 253.8522% | |
| 100.9071% | |
| 58.3378% | |
| 41.9291% | |
| 82.5731% | |
| 65.0069% | |
| 57.1601% | |
| 47.7353% | |
| 22.8226% | |
| 36.4799% | |
| 30.671% | |
| 20.5052% | |
| -11.6611% | |
| -66.275% | |
| -159.0937% | |
| -245.5366% | |
| -259.1773% | |
| -221.1004% | |
| -119.8587% | |
| -52.1351% |